|
A more recent version of this article appeared on March 3, 2006
Papers In Press, published online ahead of print December 29, 2005
J. Biol. Chem, 10.1074/jbc.M506740200
Submitted on June 21, 2005
Revised on November 17, 2005
Accepted on December 29, 2005
Tumor cells enhance their own CD44 cleavage and motility by generating hyaluronan fragments
Kazuki N Sugahara, Takako Hirata, Haruko Hayasaka, Robert Stern, Toshiyuki Murai, and Masayuki Miyasaka
Laboratory of Immunodynamics, Department of Microbiology and Immunology, Osaka University Graduate School of Medicine, Suita, Osaka 565-0871
Corresponding Author: mmiyasak{at}orgctl.med.osaka-u.ac.jp
Hyaluronan (HA) is an extracellular matrix glycosaminoglycan that interacts with cell-surface receptors, including CD44. Although HA usually exists as a high-molecular-mass polymer, HA of a much lower molecular mass that shows a variety of biological activities can be detected under certain pathological conditions, particularly in tumors. We previously reported that low-molecular-weight HAs (LMW-HAs) of a certain size range induce the proteolytic cleavage of CD44 from the surface of tumor cells and promote tumor-cell migration in a CD44-dependent manner. Here, we show that MIA PaCa-2, a human pancreatic carcinoma cell line, secreted hyaluronidases abundantly and generated readily detectable levels of LMW-HAs ranging from approximately 10- to 40-mers. This occurred in the absence of any exogenous stimulation. The tumor-derived HA oligosaccharides were able to enhance CD44 cleavage and tumor-cell motility. Inhibition of the CD44-HA interaction resulted in the complete abrogation of these cellular events. These results are consistent with the concept that tumor cells generate HA oligosaccharides that bind to tumor-cell CD44 through the expression of their own constitutive hyaluronidases. This enhances their own CD44 cleavage and cell motility, which would subsequently promote tumor progression. Such an autocrine/paracrine-like process may represent a novel activation mechanism that would facilitate and promote the malignant potential of tumor cells.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. N. Sugahara, T. Hirata, T. Tanaka, S. Ogino, M. Takeda, H. Terasawa, I. Shimada, J.-i. Tamura, G. B. ten Dam, T. H. van Kuppevelt, et al.
Chondroitin Sulfate E Fragments Enhance CD44 Cleavage and CD44-Dependent Motility in Tumor Cells
Cancer Res.,
September 1, 2008;
68(17):
7191 - 7199.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kaneiwa, S. Yamada, S. Mizumoto, A. M. Montano, S. Mitani, and K. Sugahara
Identification of a Novel Chondroitin Hydrolase in Caenorhabditis elegans
J. Biol. Chem.,
May 30, 2008;
283(22):
14971 - 14979.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Lerdrup, S. Bruun, M. V. Grandal, K. Roepstorff, M. M. Kristensen, A. M. Hommelgaard, and B. van Deurs
Endocytic Down-Regulation of ErbB2 Is Stimulated by Cleavage of Its C-Terminus
Mol. Biol. Cell,
September 1, 2007;
18(9):
3656 - 3666.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Takeda, S. Ogino, R. Umemoto, M. Sakakura, M. Kajiwara, K. N. Sugahara, H. Hayasaka, M. Miyasaka, H. Terasawa, and I. Shimada
Ligand-induced Structural Changes of the CD44 Hyaluronan-binding Domain Revealed by NMR
J. Biol. Chem.,
December 29, 2006;
281(52):
40089 - 40095.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Misra, B. P. Toole, and S. Ghatak
Hyaluronan Constitutively Regulates Activation of Multiple Receptor Tyrosine Kinases in Epithelial and Carcinoma Cells
J. Biol. Chem.,
November 17, 2006;
281(46):
34936 - 34941.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|